Live from the NIH registry
Studies recruiting near Portland right now
Top 25 of 163 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Maine Medical Center — Portland, Maine (1.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Maine Medical Partners Surgical Care — Portland, Maine (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Delirium, Neurocognitive Disorders
N/A
Interventional 1,900 participants sought
MaineHealth — Portland, Maine (1.5 mi)
· Sponsor: University of Michigan
GLP-1R Actions on Muscle and the Skeleton
Musculoskeletal Abnormalities, Obesity
Phase 4
Interventional 50 participants sought
MaineHealth Center for Clinical and Translational Science — Scarborough, Maine (7.3 mi)
· Sponsor: Pennington Biomedical Research Center
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
New England Cancer Specialists — Scarborough, Maine (7.3 mi)
· Sponsor: Gilead Sciences
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 410 participants sought
MaineHealth Institute for Research — South Portland, Maine (2.9 mi)
· Sponsor: AVEO Pharmaceuticals, Inc.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
New England Cancer Specialists — Westbrook, Maine (5.0 mi)
· Sponsor: Eli Lilly and Company
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Endometrial Cancer
Phase 1, Phase 2
Interventional 148 participants sought
Maine Medical Center — Scarborough, Maine (7.3 mi)
· Sponsor: Alliance Foundation Trials, LLC.
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
MaineHealth Maine Medical Center- Scarborough — Scarborough, Maine (7.3 mi)
· Sponsor: NRG Oncology
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
MaineHealth Cardiology - Biddeford — Biddeford, Maine (15.7 mi)
· Sponsor: Novo Nordisk A/S
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Maine Medical Center-Bramhall Campus — Portland, Maine (1.5 mi)
· Sponsor: SWOG Cancer Research Network
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting
Cardiac Valve Disease
N/A
Observational 2,150 participants sought
Maine Medical Center — Portland, Maine (1.5 mi)
· Sponsor: Corcym S.r.l
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
MaineHealth Maine Medical Center - Portland — Portland, Maine (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
MaineHealth Cancer Care and IV Therapy - South Portland — South Portland, Maine (2.9 mi)
· Sponsor: SWOG Cancer Research Network
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Maine Medical Center Bramhall — Portland, Maine (1.5 mi)
· Sponsor: Novo Nordisk A/S
Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)
Cardiac Arrest, Inflammation
N/A
Observational 400 participants sought
Maine Medical Center — Portland, Maine (1.5 mi)
· Sponsor: MaineHealth
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
MaineHealth Maine Medical Center- Scarborough — Scarborough, Maine (7.3 mi)
· Sponsor: NRG Oncology
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast Cancer, Locally Advanced Breast Cancer
Phase 3
Interventional 1,000 participants sought
Clinical Trial Site — Scarborough, Maine (7.3 mi)
· Sponsor: Olema Pharmaceuticals, Inc.
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Glioblastoma (GBM), Newly Diagnosed Glioblastoma
Phase 2
Interventional 162 participants sought
Maine Health Cancer Care and Blood Disorders - Scarborough — Scarborough, Maine (7.3 mi)
· Sponsor: Black Diamond Therapeutics, Inc.
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
MaineHealth Cancer Care and IV Therapy - South Portland — South Portland, Maine (2.9 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
MaineHealth Maine Medical Center - Portland — Portland, Maine (1.5 mi)
· Sponsor: NRG Oncology
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Breast Neoplasms, Carcinoma, Ductal, Breast
N/A
Interventional 725 participants sought
New England Cancer Specialists — Westbrook, Maine (5.0 mi)
· Sponsor: Natera, Inc.
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Phase 1, Phase 2
Interventional 75 participants sought
Maine Medical Center — Scarborough, Maine (7.3 mi)
· Sponsor: Turning Point Therapeutics, Inc.
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Cervical Cancer
N/A
Interventional 840 participants sought
Maine Medical Partners-Woman's Health-Division of Gynecologic Oncology — Scarborough, Maine (7.3 mi)
· Sponsor: GOG Foundation
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Phase 2, Phase 3
Interventional 590 participants sought
Local Institution - 0127 — Scarborough, Maine (7.3 mi)
· Sponsor: Bristol-Myers Squibb